| Bioactivity | Menin-MLL inhibitor 19, a potent exo-aza spiro inhibitor of menin-mll interaction, example A17, extracted from patent WO2019120209A1. Menin-MLL inhibitor 19 can be used for the reseaech of various diseases, such as cancer, myelodysplastic syndrome (MDS) and diabetes[1]. |
| Target | IC50: menin-mll interaction |
| Name | Menin-MLL inhibitor 19 |
| CAS | 2360487-93-8 |
| Formula | C30H34F3N7O4S |
| Molar Mass | 645.70 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Xuedong Dai, et al. Exo-aza spiro inhibitors of menin-mll interaction. Patent WO2019120209A1 |
Menin-MLL inhibitor 19
CAS: 2360487-93-8 F: C30H34F3N7O4S W: 645.70
Menin-MLL inhibitor 19, a potent exo-aza spiro inhibitor of menin-mll interaction, example A17, extracted from patent WO
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.